[Influenza vaccination present and future]

Area of Science:

• Immunology
• Virology
• Public Health

Context:

• Influenza vaccination effectiveness varies by age and health status, with reduced efficacy in individuals over 65 and those with comorbidities.
• Despite lower efficacy in preventing infection, influenza vaccination remains crucial for preventing severe outcomes in the elderly, including pneumonia, hospitalization, and death.
• Current recommendations target vaccination for individuals over 65, high-risk groups, healthcare workers, and those with occupational exposure to avian influenza.

Purpose:

• To summarize the current understanding of influenza vaccine effectiveness, safety, and recommendations.
• To highlight the benefits of influenza vaccination in preventing severe complications in the elderly and high-risk populations.
• To address the limitations of current vaccine production timelines and the need for improved and universal influenza vaccines.

Summary:

• Influenza vaccines are generally safe with rare severe complications, though effectiveness can be limited in older adults and those with underlying health conditions.
• Vaccination is particularly beneficial for the elderly, reducing hospital admissions and deaths from influenza and associated pneumonia, with greater impact in institutionalized populations.
• The annual strain selection and production process, taking up to six months, poses a challenge for rapid pandemic response, necessitating research into faster production methods and universal vaccines.

Impact:

• Influenza vaccination plays a vital role in mitigating severe disease, hospitalization, and mortality associated with seasonal influenza, particularly in vulnerable populations.
• The findings underscore the importance of continued vaccination efforts and public health strategies to protect against influenza-related morbidity and mortality.
• Advancements in vaccine technology, including accelerated production and universal vaccine development, are critical for enhancing global preparedness against influenza pandemics.